chrisvoncsefalvay/vaers-outcomes huggingface dataset:
severe allergic reaction post-vaccination; This is a spontaneous report from a contactable consumer (patient's wife). A male patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Batch/Lot number was not reported) via an unspecified route of administration on an unspecified date as dose number unknown, single for COVID-19 immunisation. Medical history included cancer and cancer surgery. The patient's concomitant medications were not reported. The patient experienced severe allergic reaction post-vaccination on an unspecified date. The event was reported as serious, medically significant and resulted in emergency room visit. Outcome of event was unknown.  The lot number for the vaccine, [BNT162B2], was not provided and will be requested during follow up.
Patient had a stroke a few days after vaccine booster.  Had less severe but similar symptoms after 2nd dose.
This spontaneous report was received from a physician via company representative, referring to two female patients who were about "20 plus" years old. Medical history and concurrent conditions of this two patients were not provided. On an unknown date, the patients were vaccinated with GARDASIL (dosage, frequency, route of administration, lot number and expiration date were not reported). No other suspect or concomitants therapies were provided. On an unknown date, both patients developed Polycystic ovarian syndrome. The reported referred that is unknown if both patients sought medical attention. No product quality complaint was involved. At the time of the report, the status of polycystic ovarian syndrome was unknown. The causality between GARDASIL and the adverse event were not provided. Additional information has been requested.
Client came in to receive the Moderna Bivalent and I accidently gave him the regular Moderna Vaccine.  This occurred at 11:52 am 11/23/22.  Client had no reactions.  I talked with client and let him know that he received the regular Moderna vaccine and not the Bivalent.  Client questions what he needs to do next.  I discussed with him that he can return in 2 months and receive the Bivalent and apologized for the error.  Asked this client if he feels ok after his 15 min wait and he says, yes.
LNP in Moderna COVID-19 Vaccine may have weakened my adaptive immune system leading to more severe COVID-19 disease. Received antibodies that seemed to help. Yet you're still authorizing emergency use of these vaccines. If I knew this I wouldn't have received the vaccine or at least would have gotten bloodwork done and compared T/B cell responses to different pathogens. Shame on you for your media and politic-induced social bias and the corollary failure to protect the public against vaccine technology that was not fully vetted. Because I'm still sifting through emerging studies and building a case, I will not share my identity.
pt recv vax 8DEC97 & 14DEC97 pt devel a varicella like rash;
Information has been received from a medical assistant concerning to unspecified number patients of unknown age and gender. Concurrent conditions, concomitant medication and medical history were not provided. On unspecified dates since 29-SEP-2016, the patients received improperly stored doses of improperly stored of GARDASIL 9 (lot # M016193, expiration date 24-APR-2018) for prophylaxis. The vaccines were stored at 31.6 F for 30 minutes. The temperature excursions were detected by a "data logger". There was no previous temperature excursion. The medical assistant was not aware of any adverse effects. This is one of several reports received from the same reporter. As of 12-DEC-2016, all telephone attempts to obtain follow up information have been unsuccessful. Additional information has been requested. Sender's Comments: US-009507513-1610USA014766: MERCK 1610USA014741: Mfr number.
pt recv vax 19FEB96 & 18APR96 pt had a negative titer;
Gave Covid 19 bivalent booster vaccination as first COVID 19 vaccine received. Order was for COVID 19 bivalent dose, vaccine drawn and administered. Whan charting administration of vaccines in patients room noticed no previous doses of COVID vaccine were recorded. Asked mother where first COVID vaccines were given. Mother states this is first COVID vaccine patient has received. Informed ordering provider, Dr. Checked documents the next day to see when another dose should be given. record documents due later, no specific date. This is a vaccine dose error, patient should have received the COVID 19 primary series vaccination.
Patient is not experiencing and adverse reactions at this time. Patient was given DTAP HEP B IPV (PEDIARIX) instead of DTAP (INFANRIX)
Rash on arm next day, took BENADRYL heart flutter was noticed on Thursday (2 days later). By Friday arm was swelled went down by Sunday.
Severe chronic pain up and down entire spine causing inability to work or perform daily functions.  Some mental confusion.
Swollen lymph nodes; heart rate went faster; had her period (menstrual cycle) twice and it's been lasting longer than usual.; neck was swollen and tight; could not walk; This is a spontaneous report received from a contactable reporter(s) (Other HCP) from medical information team. The reporter is the patient.  A female patient received bnt162b2 (COMIRNATY), administration date 2021 (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. Relevant medical history included: "allergy to sulfites" (unspecified if ongoing). The patient's concomitant medications were not reported. The following information was reported: LYMPHADENOPATHY (non-serious) with onset 2021, outcome "recovered" (2021), described as "Swollen lymph nodes"; HEART RATE INCREASED (non-serious) with onset 2021, outcome "unknown", described as "heart rate went faster"; OLIGOMENORRHOEA (non-serious) with onset 2021, outcome "unknown", described as "had her period (menstrual cycle) twice and it's been lasting longer than usual."; SWELLING (non-serious) with onset 2021, outcome "unknown", described as "neck was swollen and tight"; GAIT INABILITY (non-serious) with onset 2021, outcome "unknown", described as "could not walk". Relevant laboratory tests and procedures are available in the appropriate section.  Additional information: Asked whether she would have worse side effects after the 2nd dose, specifically regarding swollen lymph nodes. She had a side effect after the first dose of the vaccine. Asked whether she should get the second dose. She said she would call back later, she wanted to call her doctor. HCP stated that she received the 1st dose of the Pfizer COVID vaccine about 2 and 1/2 weeks ago. She experienced swollen lymph nodes that lasted more than 2 weeks. Her neck was swollen and tight, she could not walk. Her husband had a swollen lymph node in his hand after receiving the vaccine. She had to sit after she got her dose. Her heart rate went faster and felt like a rush of blood to my head. She had her period (menstrual cycle) twice and it had been lasting longer than usual. Asked regarding the efficacy after 1st dose and to give her a letter stating that she should not get the 2nd dose.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Very tired, weak, fever 100.1 to 99.1.  Arm hurt.  Felt sick for 35 hours.
I received the first shot of my Covid vaccine after having two "normal" ultrasounds, with my pregnancy progressing just fine.  I found out the baby no longer had a heartbeat on 4/23 at a routine ultrasound appointment, which was about 2 weeks after my first shot (which was on 4/8). I was told the baby was measuring 9.5 weeks, and I should have been measuring 10.5 weeks; so it's heart stopped beating about a week after the first shot. I had a d&c at 10.5 weeks.  We did bloodwork and genetic testing and all test results came back "normal".
Breakthrough case admission after 5 vaccines Moderna 2/12/21 lot# 015M20A;  Moderna 3/12/21 lot# 044A21A;  Moderna 12/16/21 LOt# 045J21A;  Moderna 4/15/22 lot# 005M21A;  Moderna 10/11/22 lot# AS7164B
pt recv vax 9SEP96 & 18SEP96 rubeola antibody titer was negative;
Tachycardia heartbeat; This is a spontaneous report from a contactable consumer, the patient. A 48-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: UNKNOWN), via an unspecified route of administration in the left arm on 28Mar2021 at 11:15 (at the age of 48-year-old), as a single dose for COVID-19 immunisation. Medical history included epilepsy, blood pressure high and fruit allergy (avocados). Concomitant medications included benazepril (MANUFACTURER UNKNOWN), hydrochlorothiazide (MANUFACTURER UNKNOWN), valproate semi sodium (DEPAKOTE) and carbamazepine (CARBAMA), all taken for an unknown indication, since unspecified dates. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 31Mar2021 at 16:00, the patient experienced tachycardia heartbeat. The adverse event did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the tachycardia heartbeat. The clinical outcome of the event tachycardia was unknown.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Patient was positive of COVID 19 in between doses; Patient was positive of COVID 19 in between doses; This is a spontaneous report from a Pfizer-sponsored program, from a contactable consumer (parent).  A male patient of an unspecified age received the first dose of BNT162B2 (Pfizer-Biontech Covid-19 Vaccine) at single dose, on an unspecified date, for COVID-19 immunisation. Relevant medical history included T-cell lymphoblastic leukemia acute (in remission). Concomitant medications were unknown. On an unspecified date, after the first dose, the patient was tested positive for COVID 19. It was confirmed that patient was positive of COVID 19 in between doses. Clinical outcome was unknown at time of this report.  The information on the lot number has been requested.
With both shots, (1st and 2nd ) dose, lost use of arms and legs, literally was unable to stand on my own.  This event started about 12 hours after receiving vaccine, lessened some after about 6 hours, was completely gone within 12 hours. First time was mostly legs, 2nd time was arms and legs.
Redness at injection site which spread to entire upper arm combined with swelling & pain. Still exists today. On night after vaccine fever of 102 combined with chills for several hours
Patient was given the hep A vaccine was light headed afterwards, had her lay down for 15 minutes. Check to see if she was okay to leave she stated she was fine. Left clinic fell outside front door of clinic and scraped left knee.
tinnitus; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). Other Case identifier(s): 2022NVX-US-000002810.  A female patient received BNT162b2 (BNT162B2), as dose number unknown, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: TINNITUS (non-serious), outcome "unknown".  Additional information: On 02Aug2022, it was reported that a patient started treatment on an unspecified date with Pfizer BioNTech COVID-19 vaccine at an unspecified date or an unspecified indication. It was reported that, the patient developed tinnitus.    No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Pt experienced a large skin eruption at site of DTaP (also received MMR and IPV at other sites). The area was blistered and very red.
Sore arm; This case was reported by a physician via call center representative and described the occurrence of pain in arm in a patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced pain in arm. On an unknown date, the outcome of the pain in arm was unknown.   It was unknown if the reporter considered the pain in arm to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported. The patient received Shingrix and had sore arm. No other details were available since this was a friend of reporter's patient. For tolerances of 2nd dose, refer case US2019AMR201660, reported by same reporter for the same patient.
Diarrhea, severe body aches, severe head ache, low grade fever, entire upper arm is extremely sore (where I received the injection), drained of any energy, overall miserable.
Patient was given 0.5ml instead of 0.25 ml booster dose, in-service and further education given to staff prior to administering further vaccinations.
Narrative:  Pt had severe headache 2 days after 1st covid vaccine (headache never went away). After second vaccine, got much worse. Seen by neurologist who did imaging and found blood clots in brain.
Pt developed facial paralysis 14 days post vaccination, went to Hospital ER and was diagnosed with Bell's Palsy.  Pt came to me, his internist, today (4/13/21) to follow up.
I began to feel my stomach become hard, bloated and constipated, went to OB doctor and family doctor and was told I was just constipated and treated for that for several months.  I started feeling pain in May and went to ER where a CT was done and was told I had a tumor.  Treatment was to have tumor removed, total hysterectomy and appendix removed.
Aching arm with swelling and limitation of movement. Pt. using TYLENOL q 4 hours for pain and cold compress (for swelling). Pt had previous PNEUMOVAX post surgery 02/02/10 and did not remember receiving it. Husband reminded her after PHN gave imm. this date - 4/22/10.
Lump in neck/it might be infected or a lymph node; Lump in neck/it might be infected or a lymph node; Lump in neck/it might be infected or a lymph node; This is a spontaneous report from a contactable consumer (patient). A patient of unspecified age and gender received the first dose of BNT162B2 (lot number: EK9231), via an unspecified route of administration on 14Jan2021 at single dose for covid-19 immunization. The patient medical history and concomitant medications were not reported. This morning (17Jan2021) patient woke up and there is a lump in neck. And patient looked at some information, patient thought it might be infected or a lymph node. The outcome of the events was unknown.
Pt dizzy, weak, pale, white lips, and nausea the next day. Site up to much of shoulder blade painful. Pt has cough, hoarseness. Advised  Mom to take her to Dr on 11/09/01.
No adverse event; Gave Moderna 6 month Monovalent vaccine to a patient and it was a vial they had from yesterdays/ Dose administered >12 hours post puncture; This spontaneous case was reported by an other health care professional and describes the occurrence of POOR QUALITY PRODUCT ADMINISTERED (Gave Moderna 6 month Monovalent vaccine to a patient and it was a vial they had from yesterdays/ Dose administered >12 hours post puncture) and NO ADVERSE EVENT (No adverse event) in a 2-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. AS1903B) for COVID-19 prophylaxis.     No Medical History information was reported.    On 14-Feb-2023, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Feb-2023 at 9:30 AM,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced POOR QUALITY PRODUCT ADMINISTERED (Gave Moderna 6 month Monovalent vaccine to a patient and it was a vial they had from yesterdays/ Dose administered >12 hours post puncture). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, POOR QUALITY PRODUCT ADMINISTERED (Gave Moderna 6 month Monovalent vaccine to a patient and it was a vial they had from yesterdays/ Dose administered >12 hours post puncture) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for POOR QUALITY PRODUCT ADMINISTERED (Gave Moderna 6 month Monovalent vaccine to a patient and it was a vial they had from yesterdays/ Dose administered >12 hours post puncture).    Patient was administered with Monovalent 6 month to 5-year-old vaccine. Patient had 1 dose from 1 vial. The vial size was unknown. The vial was initially stored in the refrigerator someday in week between 06-Feb-2023 through 11-Feb-2023, Exact date was unknown. The vial was first punctured on 13-Feb-2023 in the afternoon (exact time was not written on vial).  Patient administered the vaccine on 14-Feb-2023 09:30 am.  The vial was stored in the room temperature post puncture. The vial did not undergo any temperature excursions. The vial was exposed to room temperature range (8 degree C to 25 degree C or 46 degree F to 77 degree F) for less than 24 hours. The vial was not exposed to room temperature for more than 24 hours.   No concomitant medication reported. No treatment medication reported.
Rash on skin, face, mouth, legs; This is a spontaneous report from a contactable consumer (patient) or other non health care professional. A 21-years-old male patient received bnt162b2 (Covid-19 vaccine, Formulation: Solution for injection), via an unspecified route of administration on 12Jul2021 as dose 2, single for covid-19 immunisation The patient medical history and concomitant medications were not reported. The patient previously received BNT162B2 for Covid-19 immunization (Dose 1). On an unspecified date, the patient experienced rash on skin, face, mouth, legs. Treatment received for the adverse events. The outcome of the event was unknown.   Information about batch/ lot number has been requested.
Information has been received from a physician, via a company representative, concerning an 11 year old female patient, with a history of cancer (in remission for 5 years) , who on an unknown date was vaccinated with a dose of GARDASIL. Subsequently the patient developed a drop in her blood platelet levels to below 200 (units not specified). At the time of this report, the outcome of the event was unknown. Additional information has been requested. Initial and follow up information has been received from a physician concerning an 11 year old female with a history of cancer (in remission for 5 years), who on 05-JUN-2007 was vaccinated with a dose of VLP vaccine (lot # not provided). Subsequently the patient developed a drop in her blood platelet levels to below 200 (units not specified). It was reported that bloodwork for platelets done on 19-JUL-2007 showed a slight low count of 163, 000. This was repeated on 04-AUG-2007 and was 191,000. The patient finished chemotherapy. Additionally, it was reported that this was a case of cancer reactivation after remission. At the time of this report, the patient's outcome was unknown. Upon internal review cancer reactivation was considered to be an other important medical event.  8/25/08-records received-12/10/07-referred for recent drop in platelet count. On 7/17/07 platelet count 160,000 and some URI around same time. PE on 11/15/07 no petechiae no palpable adenopathy. Platelets now 183,000. Drop in platelets could be due to a reaction to vaccination or an infection. No evidence of leukemia relapse. May receive second vaccination. At the time of this report, the outcome of the event was unknown. Follow-up information was received which reported that bloodwork for plateletes done 19-JUL-2007 showed a slight low count of 163,000. This was repeated on 04-AUG-2007 and was 191,oo (normal). The patient finished chemotherapy.
the patient was sitting in our observation area for the recommended 15 minutes.  he fainted and fell face forward out of his chair at the 10 minute mark.  my pharmacy technician and I ran out of the pharmacy to help the patient while another technician called 911.  we rolled him to his side and he was breathing but pale.  we removed his mask and noticed his head was bleeding.  we put pressure on the would and stayed with the patient until the paramedics arrived
got COVID-19; got COVID-19; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team.  A male patient received BNT162b2 (BNT162B2 NOS), as dose number unknown, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), SUSPECTED COVID-19 (medically significant), outcome "unknown" and all described as "got COVID-19".  Additional information: The consumer stated her ex-husband and his girlfriend received the Pfizer covid-19 vaccines and later got COVID-19. The consumer did not report when and how many of the Pfizer covid-19 vaccinations her ex-husband or the girlfriend of her ex-husband received.   The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
This spontaneous report was received from a medical assistant and refers to a patient of unknown age and gender. No information regarding the patient's pertinent medical history, concomitant therapies and drug reaction or allergies was provided. On 03-OCT-2018, the patient was vaccinated with an improperly stored dose of ROTATEQ lot # R002521, expiry date 18-SEP-2019, orally for prophylaxis. The doses of vaccine were stored between 47 degrees Fahrenheit (F) to 77F for 6 hours. No previous temperature excursions were detected. Digital data logger was involved. No adverse effects were reported. This is one of two reports received from the same reporter. Sender's Comments: US-009507513-1810USA002701.
8/17/2021 Shingles on the right side all over torso back and front and arm. Anti-Viral. It is ongoing and took three weeks to improve.
Multiple mouth sores (aphthous ulcers on left cheek) within 2 days of receiving the vaccine which caused seve p
Stuffed up head and sneezing. Started on 1-3-2021. I get this every year.
administered MMR II that was improperly stored in the freezer; This spontaneous report was received from a physician and refers to a patient of unknown age and gender. No information regarding the patient's pertinent medical history, drug reactions or allergies and concomitant therapies was provided.     On 24-JUL-2020, the patient was vaccinated with an improperly stored one dose of measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live(M-M-R II) Recombinant human albumin (rHA), lot # S020161, expiration date 30-JUL-2021 (exact dose and route of administration were not reported) for prophylaxis.        Digital Data logger was involved. The vaccine was stored at the temperature that was reported as -10 degrees of F, the time frame was not reported. There was a previous temperature excursion reported as below 36 degrees of F (10 degrees of F) for 50 minutes.; Sender's Comments:  US-009507513-2008USA001787: US-009507513-2008USA002399: US-009507513-2008USA001689:
Soreness in the arm, body aches and muscle soreness the next day. Irritability, malaise, and fatigue lasting for about 3 days.
Adverse event: Arm extremely sore, Chills and fever of 100.4, nausea Treatment: advil Lasted 7:30 pm 12/30/2020 to Noon pm 1/1/2021